Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition

被引：4

作者：

Hu, Yonghan ^{[1
]}

Xing, Li ^{[1
]}

Thomason, Jennifer R. ^{[1
]}

Xiang, Jason ^{[1
]}

Ipek, Manus ^{[1
]}

Guler, Satenig ^{[2
]}

Li, Huanqiu ^{[3
]}

Sabatini, Joshua ^{[1
]}

Chockalingam, Priya ^{[4
]}

Reifenberg, Erica ^{[5
]}

Sheldon, Richard ^{[4
]}

Morris, Elisabeth A. ^{[4
]}

Georgiadis, Katy E. ^{[4
]}

Tam, Steve ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Worldwide Med Chem, Cambridge, MA 02140 USA

[2] Astra Zeneca Res Ctr, Waltham, MA 02451 USA

[3] Abbott Labs, Abbott Pk, IL 60064 USA

[4] Pfizer Global Res & Dev, Inflammat & Immunol, Cambridge, MA 02140 USA

[5] Echelon Biosci, Salt Lake City, UT 84108 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 22期

关键词：

Aggrecanase-1; MMP-13; Osteoarthritis; Biphenylsulfonamide; MATRIX-METALLOPROTEINASE INHIBITORS; SELECTIVE MMP-13 INHIBITORS; BIOLOGICAL EVALUATION; POTENT; DESIGN; IDENTIFICATION; DISCOVERY; SERIES;

D O I：

10.1016/j.bmcl.2011.09.036

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Design, synthesis and structure-activity relationship of a series of biphenylsulfonamido-3-methylbutanoic acid based aggrecanase-1 inhibitors are described. In addition to robust aggrecanase-1 inhibition, these compounds also exhibit potent MMP-13 activity. In cell-based cartilage explants assay compound 48 produced 87% inhibition of proteoglycan degradation at 10 mu g/mL. Good pharmacokinetic properties were demonstrated by 46 with a half-life of 6 h and bioavailability of 23%. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6800 / 6803

页数：4

共 50 条

[31] MicroRNA-92a-3p Regulates Aggrecanase-1 and Aggrecanase-2 Expression in Chondrogenesis and IL-1β-Induced Catabolism in Human Articular Chondrocytes
Mao, Guping
Wu, Peihui
Zhang, Ziji
Zhang, Zhiqi
Liao, Weiming
Li, Yukang
Kang, Yan
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (01) : 38 - 52
[32] Regulation of the human aggrecanase-1 (ADAMTS-4) gene promoter by NFATP and RUNX2
Thirunavukkarasu, K
Pei, Y
Yu, XP
Chandrasekhar, S
OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S95 - S96
[33] Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes
Liacini, A
Sylvester, J
Zafarullah, M
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (01) : 320 - 327
[34] TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4
Wayne, Gareth J.
Deng, Su-Jun
Amour, Augustin
Borman, Satty
Matico, Rosalie
Carter, H. Luke
Murphy, Gillian
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (29) : 20991 - 20998
[35] MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes
Tetsuya Matsukawa
Tadahiro Sakai
Tomo Yonezawa
Hideki Hiraiwa
Takashi Hamada
Motoshige Nakashima
Yohei Ono
Shinya Ishizuka
Hiroyuki Nakahara
Martin K Lotz
Hiroshi Asahara
Naoki Ishiguro
Arthritis Research & Therapy, 15
[36] Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes
Takizawa, Masayuki
Yatabe, Taku
Okada, Aiko
Chijiiwa, Miyuki
Mochizuki, Satsuki
Ghosh, Peter
Okada, Yasunori
FEBS LETTERS, 2008, 582 (19) : 2945 - 2949
[37] MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes
Matsukawa, Tetsuya
Sakai, Tadahiro
Yonezawa, Tomo
Hiraiwa, Hideki
Hamada, Takashi
Nakashima, Motoshige
Ono, Yohei
Ishizuka, Shinya
Nakahara, Hiroyuki
Lotz, Martin K.
Asahara, Hiroshi
Ishiguro, Naoki
ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)
[38] ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan
Hashimoto, G
Shimoda, M
Okada, Y
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) : 32483 - 32491
[39] Synergistic upregulation of ADAMTS4 (aggrecanase-1) by cytokines and its suppression in knee osteoarthritic synovial fibroblasts
Cilek, Mehmet Zeynel
de Vega, Susana
Shiozawa, Jun
Yoshinaga, Chiho
Miyamae, Yuka
Chijiiwa, Miyuki
Mochizuki, Satsuki
Ito, Masatoshi
Kaneko, Haruka
Kaneko, Kazuo
Ishijima, Muneaki
Okada, Yasunori
LABORATORY INVESTIGATION, 2022, 102 (01) : 102 - 111
[40] CP-MLR/PLS directed structure-activity study in modeling of the aggrecanase-1 inhibitory activity of biphenylsulfonamides
Shekhawat, Nidhi
Singh, Prithvi
INDIAN JOURNAL OF CHEMISTRY, 2024, 63 (03): : 315 - 324

← 1 2 3 4 5 →